LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Similar documents
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

Becoming a colposcopist: Colposcope case studies

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Introduction to Colposcopy

Cervical Dysplasia and HPV

Management that provides continuity of care for women

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Colposcopy. Attila L Major, MD, PhD

Cervical Conization. 1

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Management of Abnormal Cervical Cytology and Histology

CPC on Cervical Pathology

Conflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives

I have no financial interests to disclose.

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Twenty-first refresher course. Chan Kit Sheung

Human Papillomavirus (HPV) in Patients with HIV.

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Jean Anderson, MD Catherine Sewell, MD, MPH

SOGC / SCC Clinical Practice Guideline

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK

Your Colposcopy Visit

The Case of Mrs. Virginia Jones* Asst. Professor Division of Gyne-Oncology University of British Columbia, Department of Gynecology Vancouver, Canada

Understand Your Results

Cancer in the LGBTQ Community. Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine

The society for lower genital tract disorders since 1964.

High Resolution Anoscopy Overview. Naomi Jay, RN, NP, PhD University of California San Francisco

What Causes Cervical Cancer? Symptoms of Cervical Cancer

VIN/VAIN O C T O B E R 3 RD J M O R G A N

COLPOSCOPY MADE EASY AND SIMPLE

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

I have no financial interests in any product I will discuss today.

HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco

What is cervical cancer?

International Federation of Gynecology and Obstetrics

Cervical Cancer 4/27/2016

Chapter 10: Pap Test Results

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

Cervical Cancer Early Detection, Diagnosis, and Staging

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Methods of Obstetrics & Gynecology treatment

Estimated New Cancers Cases 2003

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

Vaginal intraepithelial neoplasia

EFC and European Standards for Colposcopic Evaluation

Understanding Your Pap Test Results

The Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series

Vulvar cancer: Know what to expect

HPV infections and potential outcomes

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Cervical Cancer : Pap smear

HPV-related papillomatous-condylomatous lesions in female anogenital area

Cytology Update M Laing QEUH

How might we implement screening for anal cancer in HIV-positive patients?

PREVENTION OF CERVICAL CANCER

Making Sense of Cervical Cancer Screening

E-Newsletter. Newsletter of Indian Society of Colposcopy & Cervical Pathology (Reg.)

No Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Over-diagnoses in Cytopathology: Is histology the gold standard?

Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.

Managament of Abnormal Cervical Cytology and Histology

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

Cervical Precancer: Evaluation and Management

Lauren O Sullivan, D.O. February 19, 2015

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

Should Anal Pap Smears Be a Standard of Care in HIV Management?

HPV, Cervical Dysplasia and Cancer

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

A comparative study of two methods of large loop excision of the transformation zone

Cytology Report Format

5. Colposcopist performing exam: (Draw SCJ, acetowhite, punctation, mosaics, atypical vessels, and other lesions)

Treatment of cervical intraepithelial neoplasia by loop electrosurgical excision procedure (LEEP)

BCCCP Approved ICD-9 Code List Fiscal Year 2010

Investigation of 100 consecutive negative cone biopsies

Cervical Cancer Screening. David Quinlan December 2013

HPV and PREGNANCY Arsenio Spinillo,, MD

Information on: Cervical. screening. (smear test) jostrust.org.uk

Cytyc Corporation - Case Presentation Archive - June 2003

Efficacy of cervical intrarepithelial neoplasia (CIN)

Information on: Cervical. screening. (smear test) jostrust.org.uk

Eradicating Mortality from Cervical Cancer

Transcription:

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM. A. COLPOSCOPY: DONE... T DONE... (Ad) PARTICIPANT REFUSED...3 (END) Aa. DATE OF PROCEDURE: / / M D Y Ab. COLPOSCOPY PERFORMED BY: (ENTER INITIALS OF COLPOSCOPIST/S) i ii Ac. WAS COLPOSCOPY PERFORMED BY A WIHS COLPOSCOPIST?... (A)... (PROMPT) PROMPT: IF QUESTION Ac = (I.E., COLPOSCOPY WAS PERFORMED BY A N-WIHS COLPOSCOPIST), THEN COMPLETE ACSR ATC FORM AND PROCEED TO QUESTION A. WIHS Laboratory Form L4: Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4

Ad. REASON COLPO T DONE: PROMPT: Unable to contact participant (e.g., no phone, homeless, no response to attempts)... Participant was no show for multiple appointments... Participant was too ill to be scheduled at this time... 3 Participant s work/school schedule prevented her from coming... 4 Participant moved out of area / too difficult to travel... 5 Participant is incarcerated... 6 Staff unable to obtain colpo results from primary care OB/GYN for L4 completion... 7 Other... 8 END FORM AFTER COMPLETING QUESTION Ad. A. INDICATION FOR COLPOSCOPY (CIRCLE OR FOR EACH OF THE FOLLOWING I a. Prior history of Dysplasia... b. ASCUS, AGUS, Koilocytosis or SIL on recent WIHS Pap Smear... c. Presence of visible cervical or vaginal lesions... d. Presence of visible vulvar or perianal lesions... e. Post coital bleeding when not menstruating... f. Positive HPV detection test... g. Research only... h. Other... WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4

A3. TYPE OF COLPOSCOPY PERFORMED: a. Cervical b. Vaginal c. Vulvar d. Perianal e. Anal (anoscopy) A4. WAS CERVIX PRESENT? COLPOSCOPY RESULTS: A5. CERVICAL EXAM ADEQUACY:...... (SKIP TO A0) SATISFACTORY... ENDOCERVICAL SPECULUM USED TO VISUALIZE SQUAMOCOLUMNAR JUNCTION... SQUAMOCOLUMNAR JUNCTION T VISUALIZED... 3 A6. GENERAL CATEGORIZATION OF CERVICAL COLPOSCOPY: WITHIN RMAL LIMITS... (A0) ABRMAL FINDINGS... A7. ABRMAL COLPOSCOPIC FINDINGS FOUND T FOUND a. Keratosis (leukoplakia) b. Aceto-White Epithelium c. Punctation d. Mosaicism e. Atypical Vessels f. Other WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 3 of 4

A8. WHAT PERCENT (%) OF TRANSFORMATION ZONE WAS ABRMAL? 0%... < 5%... 5% - < 50%...3 50% - < 75%...4 75% - 00%...5 A9. What quadrants are abnormal? a. Endocervix (#8)... b. Inner upper left quadrant (#9)... 6 3 c. Inner lower left quadrant (#0)... d. Inner lower right quadrant (#)... 9 8 e. Inner upper right quadrant (#)... f. Outer upper left quadrant (#3)... g. Outer lower left quadrant (#4)... 5 0 4 h. Outer lower right quadrant (#5)... i. Outer upper right quadrant (#6)... OTHER FINDINGS FOUND T FOUND LOCATION IF FOUND A0. Inflammation (A) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal A. Polyp/Papilloma (A) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal A. Condyloma acuminatum (A3) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 4 of 4

OTHER FINDINGS FOUND T FOUND LOCATION IF FOUND A3. Other: a. (A5) b. Vaginal c. Cervical d. Vulvar e. Perianal f. Anal A4. Other: a. (A5) b. Vaginal c. Cervical d. Vulvar e. Perianal f. Anal A5. WAS PAP SMEAR PERFORMED WITH THIS COLPOSCOPY? A6. CERVICAL BIOPSY TAKEN? a. ECC Performed............ (SKIP TO A7) DELAYED...3 (SKIP TO A7) REFUSED... <-7> (SKIP TO A7)...... DELAYED...3 REFUSED... <-7> b. Colposcopically Directed Punch Biopsy... (c) i) Number of punch biopsies taken: ii) Location(s) taken: (round to nearest o'clock) a. o'clock b. o'clock c. o'clock d. o'clock WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 5 of 4

c. Cervical Excisional Biopsy (other than punch biopsy)... (d) i) Location taken: o'clock to o'clock d. Loop Excision of Transformation Zone (LLETZ, LETZ, LEEP)... (e) i. ectocervical passes...(a) a. enter # of passes e. Cervical Cone Biopsy... (A7) (CIRCLE ONE TYPE) Laser... (A7) Cold Knife... (A7) Loop... 3 i. ectocervical passes (a) (ii) a. enter # of passes ii. endocervical core A7. Overall impression of Cervix (Circle the highest grade lesion). RMAL... ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 CERVIX T PRESENT...6 (A8) WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 6 of 4

a. TOTAL NUMBER OF CERVICAL LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 A8. OTHER N-CERVICAL BIOPSIES TAKEN?...... (SKIP TO A6) DELAYED...3 (SKIP TO A6) REFUSED... <-7> (SKIP TO A6) TYPE BIOPSIES TAKEN ENTER UP TO LOCATION CODES FOR EACH TYPE A9. Vaginal... (A0) a) b) A0. Vulvar... (A) a) b) A. Perianal... (A) a) b) A. Anal (Anoscopy)*... (A3) a) b) A3. Endometrial... A4. Other... (A6) b) c) a. A5. Other... (A6) b) c) a. LOCATION CODES ARE LOCATED ON PAGES 0- * COMPLETE SECTION B ON PAGES - 4 OF THIS FORM WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 7 of 4

A6. a. TOTAL NUMBER OF VAGINAL LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 b. TOTAL NUMBER OF VULVAR LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 c. TOTAL NUMBER OF PERIANAL LESIONS: A7. MAXIMUM LESION SIZE: IF LESION PRESENT, CODE AS - none... one... two...3 three...4 four...5 five to nine...6 > ten...7 a. vaginal. cm b. vulvar. cm c. perianal. cm d. anal. cm e. Other. cm (SPECIFY LOCATION) A8. TOTAL NUMBER OF BIOPSIES TAKEN (Include both cervical and non-cervical): a. TOTAL NUMBER OF BIOPSIES DELAYED OR REFUSED (Include both cervical and non-cervical): WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 8 of 4

A9. OVERALL IMPRESSION: (CIRCLE THE HIGHEST N-CERVICAL GRADE LESION) RMAL...(A33) ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 A30. LOCATION OF THE HIGHEST GRADE N-CERVICAL LESION: a) Vagina... b) Vulva... c) Perianal... d) Anal... e) Other... WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 9 of 4

A3. CIRCLE THE NUMBERS FOR THE LESION LOCATIONS: LOCATION CODES. Labium Majus (left) 7. Perianus upper left. Labium Majus (right) 8. Perianus lower left 3. Labium Minus (left) 9. Perianus lower right 4. Labium Minus (right) 30. Perianus upper right 5. Introitus (left) 3. Internal Anus 6. Introitus (right) 7. Perineum (left) 8. Perineum (right) 9. Inguinal (left) 0. Inguinal (right). Thigh (left) Thigh (right) 3. Clitoris 4. Urethra 5. Pubis 5 0 9 3 4 4 3 6 5 8 7 30 9 7 8 WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 0 of 4

A3. CIRCLE THE NUMBERS FOR LESION LOCATIONS: LOCATION CODES. Anterior vaginal wall, proximal third.. Anterior vaginal wall, medial third 3. Anterior vaginal wall, distal third 4. Left lateral vaginal wall, proximal third 5. Left lateral vaginal wall, medial third 6. Left Lateral vaginal wall, distal third 7. Posterior vaginal wall, proximal third 8. Posterior vaginal wall, medial third 9. Posterior vaginal wall, distal third 0. Right lateral vaginal wall, proximal third. Right lateral vaginal wall, medial third. Right lateral vaginal wall, distal third 3 ANTERIOR R.L. 0 4 5 6 L.L. INTROITUS FORNIX 7 9 8 POSTERIOR VAGINA AND CERVIX (DRAW OS) WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4

A33. DID YOU KW THE HIV STATUS AT THE TIME OF THIS EXAM?...... A34. WAS FOLLOW-UP VISIT SCHEDULED FOR BIOPSY?...... a) SPECIFY WHERE SCHEDULED: (M.D. OR INSTITUTION) (ADDRESS) SECTION B. ANAL COLPOSCOPY B. ANAL COLPOSCOPY: DONE... T DONE... (END) PARTICIPANT REFUSED... 3 (END) Ba. DATE OF ANAL COLPOSCOPY: / / M D Y Bb. COLPOSCOPY PERFORMED BY: (ENTER INITIALS OF COLPOSCOPIST/S) i ii WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4

B. INDICATION FOR ANAL COLPOSCOPY: a. Prior history of anal dysplasia... B3. ARE LESIONS PRESENT? B4. LESIONS b. Abnormal anal cytology... c. Presence of visible perianal lesions... d. Positive anal HPV detection test... e. Research only... f. Other......... (B8) FOUND T FOUND a. Keratosis (leukoplakia) b. Aceto-White Epithelium c. Punctation d. Mosaicism e. Atypical Vessels f. Condyloma g. Other B5. TOTAL NUMBER OF LESIONS: none... (B8) one... two...3 three...4 four...5 five to nine...6 > ten...7 WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 3 of 4

B6. MAXIMUM LESION SIZE: cm B7. LOCATION OF LESION: (REFER TO DEFINITIONS AND DIAGRAM BELOW) B8. WAS A BIOPSY TAKEN? a. Anterior... (b) i. o'clock b. Posterior... (c) i. o'clock c. Anus... d. Crypt/Columnar area... e. Rectum... f. Other......... (B0) DELAYED... 3 (B0) REFUSED... <-7> (B0) B9. NUMBER OF BIOPSIES TAKEN: B0. ASCOPIC IMPRESSION: (CIRCLE THE HIGHEST N-CERVICAL GRADE LESION) RMAL... ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 DEFINITIONS: Posterior Anterior ANUS: (Anal Canal) between Verge and Squamo-Columnar junction (Pectinate Line) CRYPT/COLUMNAR AREA: Between Squamo-Columnar junction and Ano-Rectal (AR) line AR Line Squamo - Columnar Junction A-RECTUM: Between Verge and Ano-Rectal line R L ANUS R L RECTUM: Beyond Ano-Rectal line Verge WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 4 of 4